查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614234

依普拉嗪市場：按適應症、按產品、按分銷管道、按管理方法分類 - 全球預測 2025-2030

Eprazinone Market by Indication (Bronchial asthma, Chronic / acute cough, Chronic respiratory failure), Product (Liquid, Tablet), Distribution Channel, Mode of Administation - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年依拉嗪酮市場估值為172.3億美元，預計2024年將達到186億美元，複合年成長率為8.11%，預計2030年將達到297.5億美元。

依普拉嗪酮是一種用於治療呼吸系統疾病的支氣管擴張劑，並以其治療用途為中心擁有特定的市場利基。對依拉嗪的需求主要源自於其在治療支氣管炎和氣喘等慢性呼吸道疾病的功效，透過放鬆支氣管肌肉來緩解症狀。這種藥物針對的是不斷成長的人口，因為呼吸系統疾病的盛行率正在上升，部分原因是污染增加和生活方式的改變。最終用途範圍主要是醫療保健設施，包括醫院、診所和一些門診居家照護。市場成長要素包括對有效呼吸治療的需求不斷增加以及可提高臨床效果的藥物輸送系統的進步。然而，透過策略夥伴關係關係擴大依拉嗪酮市場以及進入呼吸系統疾病流行且藥品獲取情況正在改善的新興國家，存在潛在的商機。公司應專注於研發投資，以使其產品陣容多樣化並改進配方，以提高功效並減少副作用。另一方面，嚴格的法規環境、與使用依拉嗪酮相關的潛在副作用以及競爭性替代療法的存在對市場成長構成了挑戰。其他主要限制因素包括醫療保健預算的波動和保險範圍不匹配，這可能會阻礙市場滲透。創新領域包括探索與其他呼吸系統藥物的協同效應組合，以及利用吸入器和霧化器等新穎的給藥技術來提高患者的用藥依從性。市場競爭溫和，大大小小的製藥公司相互競爭，差異化需要戰略舉措，例如聯盟和以患者為中心的方法。強大的藥品研發流程和監管合規性會對市場動態產生重大影響，公司需要優先考慮全面的安全標準和全球市場擴大策略以實現永續成長。

主要市場統計
基準年[2023] 172.3億美元
預測年份 [2024] 186億美元
預測年份 [2030] 297.5億美元
複合年成長率（%） 8.11%

市場動態：揭示快速發展的依拉嗪酮市場的關鍵市場洞察

供需的動態交互作用正在改變依拉嗪酮市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球呼吸系統疾病盛行率上升
    • 由於投資增加而擴大製藥業
  • 市場限制因素
    • 與依拉嗪酮相關的高藥物配方成本
  • 市場機會
    • 加大依拉嗪酮新劑型的開發
    • 增加依拉嗪酮的監管核准
  • 市場挑戰
    • 對依拉嗪酮的益處認知不足

波特的五力：駕馭依普拉吉農市場的策略工具

波特的五力框架是了解 Epraginone 市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對依拉嗪酮市場的外部影響

外部宏觀環境因素在塑造依拉嗪酮市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解依普拉吉農市場的競爭狀況

對依拉嗪酮市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣 Epraginone 市場供應商的績效評估

FPNV定位矩陣是評估Eprrazinone市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了依普拉嗪酮市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對依普拉嗪市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地呼吸系統疾病的發生率正在上升
      • 加大投資擴大醫藥領域
    • 抑制因素
      • 與依拉嗪酮相關的處方藥物高成本
    • 機會
      • 依拉嗪酮新劑型開發取得進展
      • 增加依拉嗪酮的監管核准
    • 任務
      • 對依拉嗪酮益處的認知有限
  • 市場區隔分析
    • 適應症：透過減少發炎和放鬆氣道來治療支氣管氣喘，對依拉嗪酮的需求增加
    • 產品：優選依拉嗪片，因為它們可以精確調整藥物劑量。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 依拉嗪市場適應症

  • 支氣管氣喘
  • 慢性/急性咳嗽
  • 慢性呼吸衰竭
  • 咳嗽
  • 慢性/急性支氣管炎的祛痰藥
  • 流感
  • 鼻炎

第7章 依拉嗪市場：依產品

  • 液體
  • 錠劑

第8章依拉嗪市場：按分銷管道

  • 電子商務平台
  • 醫院藥房
  • 網路藥房

第9章 依拉嗪酮市場管理方法

  • 靜脈
  • 口服

第10章 美洲依拉嗪酮市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區依拉嗪酮市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲依拉嗪酮市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biosynth 收購 Biochemicals 加強供應鏈服務
    • Accelerated Access Collaborative 宣布投資 1,100 萬歐元用於中風、心血管和呼吸系統疾病創新
  • 戰略分析和建議

公司名單

  • BenchChem
  • Biosynth Ltd
  • BOC Sciences
  • Clearsynth
  • HK Starshine Printing Design Co., Ltd.
  • J&H CHEM Co., Ltd.
  • MedicaPharma BV
  • MuseChem Chemicals
  • Nordic Biosite
  • Procurenet Limited
  • RR Scientific, LLC
  • RayBiotech, Inc.
  • VIVAN Life Sciences
Product Code: MRR-F97DD5A7D578

The Eprazinone Market was valued at USD 17.23 billion in 2023, expected to reach USD 18.60 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 29.75 billion by 2030.

Eprazinone, a bronchodilator utilized for respiratory disorders, has a specified market niche centered around its therapeutic application. Primarily, the need for eprazinone arises from its efficacy in treating chronic respiratory diseases such as bronchitis and asthma, offering symptomatic relief by relaxing bronchial muscles. This drug caters to a growing demographic due to the rising prevalence of respiratory diseases, partly driven by increasing pollution and lifestyle changes. The end-use scope primarily encompasses healthcare facilities, including hospitals, clinics, and some outpatient home-care settings. Market growth factors include the increasing demand for effective respiratory treatments and advancements in drug delivery systems that enhance clinical outcomes. However, potential opportunities lie in expanding eprazinone's market through strategic partnerships and tapping into emerging economies where respiratory issues are prevalent and access to medication is improving. Companies should focus on diversifying product offerings and investing in R&D for improved formulations to enhance drug efficacy and reduce side effects. On the flip side, market growth is challenged by stringent regulatory environments, potential adverse reactions associated with eprazinone usage, and the competitive presence of alternative treatments. Key limitations also include fluctuating health care budgets and insurance coverage discrepancies that may hinder market penetration. Innovation areas involve exploring synergistic combinations with other respiratory drugs and leveraging novel delivery technologies like inhalers and nebulizers for better patient adherence. The market is moderately competitive, with several small and large pharmaceutical players competing, necessitating strategic initiatives such as collaboration and patient-centric approaches for differentiation. Robust pharmaceutical R&D processes aligned with regulatory compliance can significantly influence market dynamics, encouraging businesses to prioritize comprehensive safety standards and global market expansion strategies for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.23 billion
Estimated Year [2024] USD 18.60 billion
Forecast Year [2030] USD 29.75 billion
CAGR (%) 8.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Eprazinone Market

The Eprazinone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of respiratory diseases worldwide
    • Expanding the pharmaceutical sector with increasing investments
  • Market Restraints
    • High cost of formulations of medications associated with eprazinone
  • Market Opportunities
    • Growing development of new formulations of eprazinone
    • Rising approvals for eprazinone by regulatory authorities
  • Market Challenges
    • Limited awareness associated with the benefits of eprazinone

Porter's Five Forces: A Strategic Tool for Navigating the Eprazinone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Eprazinone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Eprazinone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Eprazinone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Eprazinone Market

A detailed market share analysis in the Eprazinone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Eprazinone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Eprazinone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Eprazinone Market

A strategic analysis of the Eprazinone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Eprazinone Market, highlighting leading vendors and their innovative profiles. These include BenchChem, Biosynth Ltd, BOC Sciences, Clearsynth, HK Starshine Printing Design Co., Ltd., J&H CHEM Co., Ltd., MedicaPharma BV, MuseChem Chemicals, Nordic Biosite, Procurenet Limited, R.R Scientific, LLC, RayBiotech, Inc., and VIVAN Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Eprazinone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Bronchial asthma, Chronic / acute cough, Chronic respiratory failure, Cough, Expectorant in chronic/acute bronchitis, Flu, and Rhinitis.
  • Based on Product, market is studied across Liquid and Tablet.
  • Based on Distribution Channel, market is studied across eCommerce Platforms, Hospital Pharmacies, and Online Pharmacies.
  • Based on Mode of Administation, market is studied across Intravenous and Oral.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory diseases worldwide
      • 5.1.1.2. Expanding the pharmaceutical sector with increasing investments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulations of medications associated with eprazinone
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of new formulations of eprazinone
      • 5.1.3.2. Rising approvals for eprazinone by regulatory authorities
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness associated with the benefits of eprazinone
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Rising need for eprazinone for the management of bronchial asthma to reduce inflammation and relax the airways
    • 5.2.2. Product: Expanding preference for eprazinone tablets as they offer a convenient and precisely dosed form of the medication
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Eprazinone Market, by Indication

  • 6.1. Introduction
  • 6.2. Bronchial asthma
  • 6.3. Chronic / acute cough
  • 6.4. Chronic respiratory failure
  • 6.5. Cough
  • 6.6. Expectorant in chronic/acute bronchitis
  • 6.7. Flu
  • 6.8. Rhinitis

7. Eprazinone Market, by Product

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Tablet

8. Eprazinone Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. eCommerce Platforms
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies

9. Eprazinone Market, by Mode of Administation

  • 9.1. Introduction
  • 9.2. Intravenous
  • 9.3. Oral

10. Americas Eprazinone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Eprazinone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Eprazinone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Biosynth acquires Vio Chemicals to Fortify its Supply Chain Services
    • 13.3.2. Accelerated Access Collaborative announces Euro 11 million investment in stroke, cardiovascular disease and respiratory innovations
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BenchChem
  • 2. Biosynth Ltd
  • 3. BOC Sciences
  • 4. Clearsynth
  • 5. HK Starshine Printing Design Co., Ltd.
  • 6. J&H CHEM Co., Ltd.
  • 7. MedicaPharma BV
  • 8. MuseChem Chemicals
  • 9. Nordic Biosite
  • 10. Procurenet Limited
  • 11. R.R Scientific, LLC
  • 12. RayBiotech, Inc.
  • 13. VIVAN Life Sciences

LIST OF FIGURES

  • FIGURE 1. EPRAZINONE MARKET RESEARCH PROCESS
  • FIGURE 2. EPRAZINONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPRAZINONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPRAZINONE MARKET DYNAMICS
  • TABLE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPRAZINONE MARKET SIZE, BY BRONCHIAL ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC / ACUTE COUGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC RESPIRATORY FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPRAZINONE MARKET SIZE, BY COUGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPRAZINONE MARKET SIZE, BY EXPECTORANT IN CHRONIC/ACUTE BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPRAZINONE MARKET SIZE, BY FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPRAZINONE MARKET SIZE, BY RHINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPRAZINONE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPRAZINONE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPRAZINONE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPRAZINONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2030 (USD MILLION)
  • TABLE 193. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2023